Name: Valneva向歐洲以外尋找疫苗合作伙伴 (Valneva looks beyond Europe for vaccine partner)
Uploaded: 2021-02-10T18:30:28.000Z
Duration: 1 min 45 s

French pharmaceutical company Val Niva is in the market for potential partnerships for its co vid 19 vaccine.

法國製藥公司Val Niva正在為其co vid 19疫苗尋找潛在的合作伙伴。

情態副詞

Should the candidates secure approval and gain interest beyond Britain and the European Union, The drugmaker is looking particularly at entry into the US market, according to its chief financial officer, David Lawrence.

如果候選人獲得準許並獲得英國和歐盟以外的利益，該製藥商正在尋找特別是進入美國市場，根據其首席財務官大衛-勞倫斯。

So we're not thinking very carefully about how we can participate us.

所以我們沒有很仔細的考慮如何參與我們。

I'm going forward so that Zaveri active internal discussion that we're having to think about now the administration's change now that the US has got vaccines, how do we participate in that further out?

我往前走，所以扎維裡積極的內部討論，我們要思考現在政府的變化，現在美國已經有了疫苗，我們如何參與到更遠的地方？

Val Nevas is the only French shot close to entering late stage human trials, with Britain due to receive the first doses produced in late September at the earliest.

Val Nevas是唯一一個接近進入後期人體試驗的法國鏡頭，英國最早將在9月下旬收到第一批生產的劑量。

A deal for 190 million doses has been agreed with the U.

已經與美國達成了1.9億劑的協議。

K by 2025 which could be worth up to €1.4 billion.

Lawrence says he expects talks with the European Union for a provisional 60 million doses to conclude within the next few months.

勞倫斯說，他預計與歐盟就臨時6000萬劑量的談判將在未來幾個月內結束。

Production of those vaccines will take place in Scotland on Lawrence told Reuters on Monday.

這些疫苗的生產將在蘇格蘭進行勞倫斯週一告訴路透社。

They'll think very hard about partnering with different regions if demand goes beyond that facilities capacity, Although he did not say whom the company might team up with, any partnership, might involve both production and access to markets.

如果需求超出了該設施的能力，他們會認真考慮與不同地區的合作，雖然他沒有說公司可能與誰合作，但任何合作，都可能涉及到生產和市場準入。

 Veneva said its provisional Phase three trial plan after April would involve 4000 test subjects across Britain on would likely involve a comparison against a proven vaccine rather than a placebo. 

Veneva表示，其4月後的臨時三期試驗計劃將涉及英國各地的4000名測試對象上將可能涉及與已證實的疫苗而不是安慰劑的比較。